1. Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia
   Michael L. Martini et al, 2019, Journal of Movement Disorders CrossRef
2. Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells
   Chun-Yi Lai et al, 2021, Frontiers in Pharmacology CrossRef
3. Antioxidant Effect of Alpha-Lipoic Acid in 6-Hydroxydopamine Unilateral Intrastriatal Injected Rats
   Pavlina Andreeva-Gateva et al, 2020, Antioxidants CrossRef
4. Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
   Michał Rakowski et al, 2022, International Journal of Molecular Sciences CrossRef
5. Fisetin Ameliorates Levodopa-Induced Dyskinesia in Experimental Model Parkinson's Disease: Role of Mitochondrial Activities and Monoamines Turnover
   Wenhui Cao et al, 2022, Natural Product Communications CrossRef
6. Role of Dietary Supplements in the Management of Parkinson’s Disease
   Michele Ciulla et al, 2019, Biomolecules CrossRef
7. Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
   Marianna Tosato et al, 2019, Biomolecules CrossRef
8. Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
   E. Maruthi Prasad et al, 2020, Antioxidants CrossRef